Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
Post# of 145
Next 10
Reply Private New
Public Reply Private Reply New Post
Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

whytestocks

Send PM
Followers 120
Posts 15141
Boards Moderated 2
Alias Born 06/04/2018

whytestocks

Re: None

Wednesday, 09/04/2019 8:30:32 AM

Wednesday, September 04, 2019 8:30:32 AM

Post# of 145
News: $CYAD Celyad Successfully Doses First Patient with CYAD-01 Produced with OptimAb Manufacturing Process

MONT-SAINT-GUIBERT, Belgium, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced the successful administration of CYAD-01 produced with...

Got this from CYAD - Celyad Successfully Doses First Patient with CYAD-01 Produced with OptimAb Manufacturing Process
Public Reply Private Reply New Post
Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CYAD News
More CYAD News
InvestorsHub NewsWire

CGrowth Capital Consolidates Lithium Tenement Portfolio in Tanzania Amid Renewed Mining Confidence • CGRA • May 25, 2023 11:05 AM

Interactive Strength Inc. d/b/a FORME Launches European Expansion Plan by Focusing on Strategic Partnership with SIGNA Sports United • TRNR • May 24, 2023 10:14 AM

Nextech3D.ai Game-Changing Generative-AI CAD 3D Design Studio Toggle3D.ai Primed For $7 Million June IPO • NTAR • May 24, 2023 10:00 AM

Kaya Holdings, Inc.'s V.P. Bryan Arnold Among First Ten (10) State Licensed Psilocybin Facilitators in U.S.A. • KAYS • May 24, 2023 9:48 AM

ILUS Confirms Its First Quarter of 2023 Results • ILUS • May 23, 2023 9:34 AM

SKYX Set to Join Russell 2000® and Russell 3000® Indexes • SKYX • May 23, 2023 8:56 AM

Start posting your company's news
Only $200 per official company press release!